FDA Approves Lantedra, the First Cell Therapy for Type 1 Diabetes Using Deceased-Donor Pancreatic Cells
translation exclusiveThe U.S. Food and Drug Administration has approved Lantedra as the first cell therapy made from deceased-donor pancreatic cells to treat type 1 diabetes. According to the U.S. Food and Drug Administration, Lantedra is approved for the treatment of adults with type 1 diabetes who are unable to approach their target glycated hemoglobin due … Read more